首页> 外文OA文献 >PDB55 The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

【2h】

PDB55 The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

机译：PDB55 Canagliflozin（Cana）与Sitagliptin（Sita）作为二甲双胍或Metformin加Sulphonylurea的添加剂在西班牙治疗2型糖尿病中的成本效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nielsen A.T.; Pitcher A.; Lovato E.; Schubert A.; Hemels M.; Neslusan C.; González B.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type2 diabetes mellitus [J] . DaviesM.J., ChubbB.D., SmithI.C., Diabetic medicine: A journal of the British Diabetic Association . 2012,第3期

机译：利拉鲁肽与磺脲类或西他列汀相比的成本-效用分析，均作为2型糖尿病二甲双胍单药治疗的补充
2. Cost-effectiveness of canagliflozin versus sitagliptin when added to metformin and sulfonylurea in type 2 diabetes in Canada [J] . Journal of population therapeutics and clinical pharmacology . 2016,第2期

机译：在加拿大二甲双胍和磺酰脲类中加入卡格列净与西他列汀的成本效益
3. Cost-effectiveness of Canagliflozin versus Sitagliptin When Added to Metformin and Sulfonylurea in Type 2 Diabetes in Canada [J] . Suthakar Sabapathy, Cheryl Neslusan, Kim Yoong, Journal of population therapeutics and clinical pharmacology . 2016,第2期

机译：Canagliflozin与Sitagliptin在加拿大2型糖尿病中加入二甲双胍和磺脲类药物的成本效益
4. Controlled Release of Metformin Loaded Polyvinyl Alcohol (PVA) Microbubble/Nanoparticles Using Microfluidic Device for the Treatment of Type 2 Diabetes Mellitus [C] . Sumeyye Cesur, Muhammet Emin Cam, Fatih Serdar Sayin, International work-conference on bioinformatics and biomedical engineering . 2020

机译：使用微流体装置控制二甲双胍负载的聚乙烯醇（PVA）微泡/纳米颗粒的控释，用于治疗2型糖尿病
5. Metformin use and the incidence of colorectal and lung cancer in patients with type 2 diabetes mellitus [D] . Smiechowski, Brielan. 2012

机译：二甲双胍的使用与2型糖尿病患者大肠癌和肺癌的发生率
6. Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin all as add-on to metformin monotherapy in Type 2 diabetes mellitus [O] . M J Davies, B D Chubb, I C Smith, -1

机译：利拉鲁肽与磺脲类药物或西他列汀相比的成本-效用分析均作为2型糖尿病二甲双胍单药治疗的补充
7. PDB14 Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil [O] . Pititto L, Neslusan C, Teschemaker AR, 2015

机译：PDB14在巴西2型糖尿病（T2dm）患者中，Canagliflozin（Cana）与Sitagliptin（Sita）作为二甲双胍加磺脲类药物的成本效益

PDB55 The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

著录项

引文网络

相似文献

相关主题

期刊订阅